These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 10048430
21. Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registry. Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Chuncharunee S, Niparuck P, Ekwattanakit S, Khuhapinant A, Norasetthada L, Nawarawong W, Makruasi N, Kanitsap N, Sirijerachai C, Chansung K, Wong P, Numbenjapon T, Prayongratana K, Suwanban T, Wongkhantee S, Praditsuktavorn P, Intragumtornchai T, Thai Lymphoma Study Group. Ann Hematol; 2017 Jan; 96(1):57-64. PubMed ID: 27752821 [Abstract] [Full Text] [Related]
22. Isolated central nervous system relapse in a child with non- Hodgkin lymphoma during treatment. Kebudi R, Tüysüz G, Doğan Ö, Özdemir N. Turk J Pediatr; 2014 Jan; 56(1):85-7. PubMed ID: 24827953 [Abstract] [Full Text] [Related]
23. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study. Cai QQ, Hu LY, Geng QR, Chen J, Lu ZH, Rao HL, Liu Q, Jiang WQ, Huang HQ, Lin TY, Xia ZJ. Chin J Cancer; 2016 Sep 13; 35(1):87. PubMed ID: 27624700 [Abstract] [Full Text] [Related]
24. Non-Hodgkin's lymphoma involving the central nervous system. Wolf MM, Olver IN, Ding JC, Cooper IA, Liew KH, Madigan JP. Aust N Z J Med; 1985 Feb 13; 15(1):16-21. PubMed ID: 3859259 [Abstract] [Full Text] [Related]
25. Evaluation of cerebrospinal clonal gene rearrangement in newly diagnosed non-Hodgkin's lymphoma patients. Nachmias B, Sandler V, Slyusarevsky E, Pogrebijski G, Kritchevsky S, Ben-Yehuda D, Goldschmidt N, Gatt ME. Ann Hematol; 2019 Nov 13; 98(11):2561-2567. PubMed ID: 31515574 [Abstract] [Full Text] [Related]
26. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma. Bierman P, Giglio P. Hematol Oncol Clin North Am; 2005 Aug 13; 19(4):597-609, v. PubMed ID: 16083825 [Abstract] [Full Text] [Related]
27. Successful treatment of non-Hodgkin's lymphoma of the central nervous system with BMPD chemotherapy followed by radiotherapy. Korfel A, Thiel E. Leuk Lymphoma; 1998 Aug 13; 30(5-6):609-17. PubMed ID: 9711923 [Abstract] [Full Text] [Related]
28. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Hausdorff J, Davis E, Long G, Hoppe R, van der Pas M, Lassman C, Kamel O, Jacobs C. Cancer J Sci Am; 1997 Aug 13; 3(5):303-11. PubMed ID: 9327155 [Abstract] [Full Text] [Related]
29. Central nervous system involvement in patients with mantle cell lymphoma. Oinonen R, Franssila K, Elonen E. Ann Hematol; 1999 Mar 13; 78(3):145-9. PubMed ID: 10211757 [Abstract] [Full Text] [Related]
30. Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience. Pectasides D, Economopoulos T, Kouvatseas G, Antoniou A, Zoumbos Z, Aravantinos G, Tsatalas C, Halikia A, Nikolaides C, Kiamouris C, Pappa E, Pavlidis N, Skarlos D, Fountzilas G, Dimopoulos MA. Oncology; 2000 May 13; 58(4):286-92. PubMed ID: 10838493 [Abstract] [Full Text] [Related]
31. Risk factors for central nervous system involvement in non-Hodgkins-lymphoma--a multivariate analysis. Keldsen N, Michalski W, Bentzen SM, Hansen KB, Thorling K. Acta Oncol; 1996 May 13; 35(6):703-8. PubMed ID: 8938217 [Abstract] [Full Text] [Related]
32. Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma. Oksenhendler E, Gerard L, Dubreuil ML, Levy Y, Matheron S, Cazals-Hatem D, Chevret S, Clauvel JP. Leuk Lymphoma; 2000 Sep 13; 39(1-2):87-95. PubMed ID: 10975387 [Abstract] [Full Text] [Related]
33. Central nervous system involvement in AIDS-related lymphomas. Barta SK, Joshi J, Mounier N, Xue X, Wang D, Ribera JM, Navarro JT, Hoffmann C, Dunleavy K, Little RF, Wilson WH, Spina M, Galicier L, Noy A, Sparano JA. Br J Haematol; 2016 Jun 13; 173(6):857-66. PubMed ID: 27062389 [Abstract] [Full Text] [Related]
34. [Primary gastrointestinal non-Hodgkin's lymphoma in two Hungarian regions]. Kollár B, Rajnics P, Hunyady B, Zeleznik E, Jakucs J, Egyed M. Orv Hetil; 2009 Aug 30; 150(35):1649-53. PubMed ID: 19692309 [Abstract] [Full Text] [Related]
35. Characteristic features of malignant lymphoma with central nervous system involvement. Yoshida S, Morii K, Watanabe M, Saito T. Surg Neurol; 2000 Feb 30; 53(2):163-7. PubMed ID: 10713195 [Abstract] [Full Text] [Related]
36. Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis. Recht L, Straus DJ, Cirrincione C, Thaler HT, Posner JB. Am J Med; 1988 Mar 30; 84(3 Pt 1):425-35. PubMed ID: 3348245 [Abstract] [Full Text] [Related]
37. [Isolated central nervous system relapse of diffuse large B-cell lymphoma in the era of immunochemotherapy]. Krmek DZ, Ljubić N, Vrbanić L. Acta Med Croatica; 2012 Dec 30; 66(5):403-7. PubMed ID: 23814970 [Abstract] [Full Text] [Related]
38. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ. Biol Blood Marrow Transplant; 2008 Jun 30; 14(6):685-92. PubMed ID: 18489994 [Abstract] [Full Text] [Related]
39. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology. Márky I, Björk O, Forestier E, Jónsson OG, Perkkiö M, Schmiegelow K, Storm-Mathiesen I, Gustafsson G, Nordic Society of Pediatric Hematology and Oncology. J Pediatr Hematol Oncol; 2004 Sep 30; 26(9):555-60. PubMed ID: 15342981 [Abstract] [Full Text] [Related]
40. Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation. Oshima K, Kanda Y, Yamashita T, Takahashi S, Mori T, Nakaseko C, Fujimaki K, Yokota A, Fujisawa S, Matsushima T, Fujita H, Sakura T, Okamoto S, Maruta A, Sakamaki H, Kanto Study Group for Cell Therapy. Biol Blood Marrow Transplant; 2008 Oct 30; 14(10):1100-1107. PubMed ID: 18804039 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]